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ABSTRACT 
Hydrogen peroxide (H2O2) is a reactive oxygen species (ROS) generated in the stereoselective deamination of 
D-amino acids catalyzed by o-amino acid oxidase ( D A A O ) . H 2 O 2 readily crosses cellular membranes and dam-
ages D N A , proteins, and lipids. The scarcity of D A A O substrates in mammalian organisms and its co-local-
ization with catalase in the peroxisomal matrix suggested that the cytotoxicity of R O S could be harnessed by 
administration of o-amino acids to tumor cells ectopically expressing D A A O in the cytoplasm. T o evaluate 
this hypothesis, the c D N A encoding the highly active D A A O from the red yeast Rhodotorula gracilis was m u -
tated to remove the carboxy-terminal peroxisomal targeting sequence. A clonal line of 9L glioma cells stably 
transfected with this construct {9LdaaoYI) was found to synthesize active R. gracilis D A A O . Exposure of 
9\-idaaoll cells to o-alanine resulted in cytotoxicity at concentrations that were nontoxic to parental 9L cells. 
Depletion of cellular glutathione further sensitized 9V.daaoVl cells to D-alanine (o-Ala). This result, combined 
with stimulation of pentose phosphate pathway activity and the production of extracellular H 2 O 2 by 9L,daao\l 
cells incubated with D-alanine implicates oxidative stress as the mediator of cytotoxicity. These results demon-
strate that expression of R. gracilis D A A O in tumor cells confers chemosensitivity to o-alanine that could be 
exploited as a novel cancer gene therapy paradigm. 
OVERVIEW SUMMARY 
Gene-directed enzyme prodrug therapy (GDEPT) is an an-
tineoplastic treatment strategy designed to overcome the 
systemic toxicity of chemotherapy by specifically express-
ing a foreign enzyme in malignant cells that converts a non-
toxic prodrug into a cytotoxic metabolite. The relative in-
efficiency of current in situ gene transfer methodology 
suggests that enzyme/prodrug combinations that produce 
membrane permeable metabolites will elicit a more favor-
able therapeutic response. Ideally, the agent produced by 
the transduced cell "factories" would be cytotoxic toward 
both proliferating and quiescent cells. W e describe a novel 
G D E P T approach using D-amino acid oxidase from the red 
yeast Rhodotorula gracilis and D-alanine as a substrate that 
generates hydrogen peroxide, a reactive metabolite of oxy-
gen that has both these characteristics. W e also demonstrate 
the ability to sensitize tumor cells to this G D E P T protocol 
by manipulating cellular antioxidant pathways. 
INTRODUCTION 
SINGLE ELECTRON REDUCTIONS of molecular oxygen give rise 
to a series of toxic compounds. These reactive oxygen 
species (ROS) are generated by ionizing radiation, drugs, and 
environmental pollutants, as well as by normal metabolism. Hy-
drogen peroxide (H2O2) is a ROS produced in cells by oxidases 
and spontaneous or enzymatic superoxide anion dismutation. 
H2O2 readily crosses cellular membranes and is known to dam-
age biopolymers, including D N A (Beckman and Ames, 1997; 
Henle and Linn, 1997), proteins (Beriett and Stadhnan, 1997), 
and lipids by direct oxidation or via ttansition metal-driven 
Haber-Weiss reduction to the exttemely reactive hydroxyl rad-
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ical (Halliwell and Gutteridge, 1989). Recent evidence also in-
dicates that H2O2 may induce apoptosis (Hockenbery et al, 
1993; Kane et al, 1993; Johnson et al, 1996; Simizu et al, 
1996; Bladier et al, 1997). 
Although the majority of interest in R O S has been directed 
to tiieir role in pathophysiology, it is appreciated that the cyto-
toxicity of R O S plays a mechanistic role in a number of anti-
neoplastic therapies. The most widely employed of these modal-
ities is radiation therapy, which produces hydroxyl radicals by 
direct radiolytic attack on water. R O S have also been impli-
cated as cytotoxic mediators for a number of chemotherapeu-
tic agents including bleomycin, doxorubicin, and others. Ex-
perimental tteatment modalities have been designed to produce 
R O S speciflcally in tumors. These range from photodynamic 
therapy (Halliwell and Gutteridge, 1989) to treatment of tumor-
bearing patients or animals with preformed H2O2 (Makino and 
Tanaka, 1953; Tumer, 1953; Green and Westtop, 1958; Sug-
ara, 1958; Mealy, 1965). Investigators have also employed the 
ROS-generating enzymes xanthine oxidase (XO) (Yoshikawa 
et al, 1995) and glucose oxidase (GO) as anti-cancer agents. 
Nathan and Cohn pioneered this approach in vivo when they 
demonsttated that G O conjugated to carboxylated latex mi-
crospheres prevented tumor cell growth in mice (Nathan and 
Cohn, 1981). Liposome-encapsulated glucose oxidase has also 
been used to eradicate experimental plasmacytomas (Samoszuk 
et al, 1996). Previously, we have demonsttated that inttatu-
moral H2O2 production following injection of polyethylene gly-
col (PEG)-stabilized G O into established subcutaneous rat 9L 
tumors resulted in a significant tumor growth delay (Ben-
Yoseph and Ross, 1994). However, regulation of R O S produc-
tion by exogenously administered G O in tumor-bearing hosts 
is problematic because the availability of its substtates, oxygen 
and glucose, cannot be significantiy modulated. In fact, the un-
regulated production of R O S by inttatumoral P E G - G O injec-
tions required administtation of antioxidants to minimize sys-
temic toxicity. Similarly, although X O is a lower-activity 
enzyme than G O , its production of superoxide cannot be regu-
lated in vivo because it is a promiscuous enzyme with a wide 
range of ubiquitous substrates (Massey, 1973). 
To overcome the limitations of G O and X O , we have pro-
posed the use of D-amino acid oxidase (DAAO; E C 1.4.3.3) for 
cancer tteatment (Ben-Yoseph and Ross, 1994). D A A O cat-
alyzes the stereoselective oxidative deamination of D-amino 
acids via the following reaction: 
D-amino acid -I- H2O -I- O2 ^ a-keto acid -I- NH3 -I- H2O2 
The stereoselectivity oi Rhodotorula gracilis DAAO appears to 
be absolute; L-amino acids are neither substrates nor inhibitors 
of the R. gracilis enzyme (PoUegioni et al, 1992). Although 
mammalian D A A O can oxidize glycine, the only achiral amino 
acid, glycine is a poor substtate for the D A A O homolog from 
the red yeast R. gracilis that required 300 m M glycine to ob-
serve any enzyme-monitored activity (PoUegioni et al, 1992). 
Thus, production of R O S by R. gracilis D A A O in tumor cells 
could be regulated by exogenous administration of o-amino 
acids that are rare in mammalian organisms (Konno and Ya-
sumura, 1992). Moreover, R. gracilis can grow on D-Ala as a 
sole carbon and nitrogen source (Pilone et al, 1989) and its 
D A A O homolog is catalytically efficient. This isoform tightiy 
binds its F A D co-factor (Casalin et al, 1991) and has been re-
ported to have a specific activity of 180 U/mg at 37°C with d-
Ala substtate, as well as low substtate Kyi values (submillimo-
lar for many D-amino acids) (PoUegioni et al, 1992). In 
conttast, mammalian D A A O homologs are comparatively in-
active. For example, the K ^ for D-Ala is 6.5 m M for hog kid-
ney D A A O , whereas the K ^ for beef kidney enzyme is un-
measurable because it shows no activity, even at concenttations 
of D-Ala approaching its solubility limit of 1.2 Af (D'Aniello et 
al, 1993b; PoUegioni et al, 1993). 
L o w levels of D A A O activity can be found in mammalian 
tissues (ranging from 0.81 to 780 mU/g wet tissue (Weimar and 
Neims, 1977; D'Aniello et al, 1993a), however endogenous 
D A A O is localized to the peroxisomal matrix where high cata-
lase activity can detoxify the H2O2 by-product. In fact, all 
known D A A O sequences contain type 1 peroxisomal targeting 
sequences (Faotto et al, 1995). This co-localization of en-
dogenous D A A O and catalase, along with its relatively low spe-
cific activity, is likely to account for the minimal toxicity of d-
amino acids in mammals. This is evidenced by the fact that 
administration of high doses (2 grams/kg body weight) of d-
Ala, a substtate of choice for R. gracilis D A A O , produced no 
histopathological changes in rat kidney proximal mbule cells, 
where the highest level of D A A O activity is found (Kaltenbach 
et al, 1979). 
The practical application of ROS-generating enzyme systems 
has also been hampered by difficulty in enzyme delivery. Ad-
vances in gene transfer technology offer the possibility of over-
coming this shortcoming by inttoducing the c D N A s encoding 
enzymes into malignant cells. Such cancer gene therapy para-
digms depend on expressing genes encoding nonmammalian 
enzymes that convert pharmacologically mert prodrugs to 
highly toxic metabolites. Rhodotorula gracilis D A A O is well 
suited to this delivery approach because unlike G O and X O , its 
constitutive expression is not anticipated to be cytotoxic due to 
the lack of endogenous substtates. Furthermore, H2O2 is rela-
tively stable, membrane permeable, and is cytotoxic to both pro-
liferating and quiescent cells. These characteristics are poten-
tial advantages over tiie cytotoxic agents produced by a number 
of other enzyme/prodrug combinations that have been designed 
for gene-directed enzyme prodrug therapy (GDEPT) protocols 
(Connors, 1995). 
In the present study, w e investigated G D E P T using tiie R. 
gracilis D A A O c D N A . W e have successfully expressed ac-
tive R. gracilis D A A O lacking its carboxy-terminal peroxiso-
mal targeting sequence in rat 9L gliosarcoma cells. Overex-
pression of cytoplasmically targeted D A A O in 9L tumor cells 
(Fig. l,Rxn. 1) conferred toxicity to D-Ala exposure. W e have 
atttibuted this cytotoxicity to the induction of oxidative stress 
by overproduction of H2O2 leading to generation of hydroxyl 
radical (Fig. 1, Rxn. 2) by demonsttating that DAAO-ex-
pressing cells respond to D-Ala exposure by stimulating glu-
cose flux through the pentose phosphate pathway (PPP), which 
is linked to glutathione peroxidase removal of H2O2 (Fig. 1, 
Rxns. 4-6). Additionally, exttacellular H2O2 was detected in 
the incubation buffer of DAAO-expressing cells following ex-
posure to D-Ala. Finally, DAAO-expressing cells were further 
sensitized to D-Ala by depletion of reduced glutathione (Fig. 
1, Rxn. 7), further implicating oxidative sttess as the mecha-
nism of cytotoxicity. These data demonsttate the concept of 
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FIG. 1. Schematic representation of H2O2 metabolism in cells 
expressing DAAO. Inttacellular H2O2 generated by D A A O 
(Rxn. 1) can be reduced to hydroxyl radicals via ttansition metal 
catalyzed Haber-Weiss chemistry (Rxn. 2). Hydroxyl radical re-
acts with DNA, lipids, and protein, inducing cell death. Alter-
natively, H2O2 can be removed by catalase (catalase, Rxn. 3) in 
the peroxisomes or by glutathione peroxidase (GPx, Rxn. 4) in 
the cytosol or at the plasma membrane. The G SH consumed in 
the second reaction is regenerated by glutathione reductase 
(Rxn. 5), using N A D P H produced by the oxidative branch of 
the PPP as reducing equivalents (Rxn. 6). GPx activity can be 
inhibited by depleting the de novo synthesis of GSH with l-
butiiionine-(5,/f)-sulfoximine (BSO), a specific inhibitor of y-
glutamylcysteine synthetase (Rxn. 7). 
GDEPT with an ROS-generating oxidase for the treatment of 
neoplastic disease. 
MATERIALS AND METHODS 
Plasmid construction 
The 1.2-kb Eco RI fragment from the plasmid pKK223.3-
D A A O encoding the R. gracilis D A A O cDNA (GenBank 
U60066) (PoUegioni et al, 1997) was ligated into tiie poly-
cloning site of the selectable eukaryotic expression vector 
PCDNA3.1"'" (Invittogen) to construct pcDAO. A high-fidelity 
PCR mutagenesis strategy employing a mixture of Pwo and Taq 
polymerases (Expand, Boehringer Mannheim) was used to in-
sert a eukaryotic ttanslation initiation sequence (Kozak, 1989) 
and a unique Cla I site for screening. Two overlapping muta-
genic oligonucleotides containing the Kozak sequence and Cla 
I site and two flanking oligonucleotides, one complementary to 
pcDNA3.1 and containing a unique Nde I site and the otiier 
complementary to a unique Sac U site in D A A O , were used to 
amplify 0.5-kb and 0.6-kb products. Aliquots from these sepa-
rate reactions were combined in a subsequent PCR amplifica-
tion to produce a 1.1-kb product that was digested with Nde I 
and Sac II and ligated in the sinularly digested template 
pcDAO. The resulting plasmids were screened for the mutation 
by digestion with Cla I. Mutagenesis was confmned and PCR 
amplification misincorporations were checked by automated se-
quencing (Biomedical Research Core Facilities, U M M C ) of the 
plasmid pcKDAO. The carboxy-terminal Ser-Lys-Thr type-1 
peroxisomal targeting sequence (PTS) of the D A A O insert was 
removed by mutating the TCG codon encoding the Ser to an 
amber stop codon with the Altered Sites II in vitro Mutagene-
sis System (Promega). Codon substitution was confirmed by 
automated sequencing and the mutagenized insert was recloned 
into the Eco RI site of pcDNA3.1 to make pcKDAOC. All mu-
tants were also subcloned into bacterial expression vectors with 
native 5' untranslated sequence. 
Cell culture, stable transfection, and cellular lysates 
Rat 9L gliosarcoma cells were cultured in minimum essen-
tial medium (MEM) supplemented with 10% fetal bovine serum 
(FBS), 2 m M glutamine, and antibiotics at 37°C in a humidi-
fied incubator with a 5% C02/95% air atmosphere. Cells were 
split by trypsinization once a week and were discarded after 30 
passages. Exponentially growing cells were split 1:10 onto 10-
cm tissue culture dishes the day before ttansfection with 30 /xg 
of pcKDAOC using the standard calcium phosphate precipita-
tion method (Ausbel et al, 1994). Stable ttansfectants were se-
lected by growth in 0.5 mg/ml G418 and individual clones were 
isolated on trypsin-impregnated filter paper disks (Domann and 
Martinez, 1995). Total cellular lysates were prepared by lifting 
adherent cells in 40 m M Tris, 1 mAf EDTA, 150 mAf NaCl pH 
7.4 buffer. For Westem blotting, cell pellets were resuspended 
in 250 m M Tris pH 7.6 and lysed by brief sonication on ice. 
For enzyme assays, cell pellets were resuspended in 50 m M 
Na2H2P207 pH 8.3 and briefly sonicated. All exttact super-
natants were clarified by two sequential microcentrifugation 
steps at 4°C. 
Immunoblotting 
Equal amounts of protein, as determined by the bicinchoninic 
acid (BCA) protein assay (Pierce), were resolved by 
SDS/PAGE and transferted to nitrocellulose membranes 
(Laemmli, 1970; Towbin et al, 1979). Immunodetection of 
D A A O was performed using affinity-purified rabbit polyclonal 
antibodies raised against purified R. gracilis D A A O holoen-
zyme (Perotti et al, 1991). A peroxidase-conjugated goat-anti-
rabbit immunoglobulin G (IgG) secondary antibody (Sigma) 
was used with 5-bromo-4-chloro-3-indolyl phosphate and ni-
tto-blue-tettazolium chloride to visualize the antigen-antibody 
complex. 
Enzyme and glutathione assays 
DAAO activity was measured with a horseradish peroxidase 
(HRP)-coupled, specttophotometric assay using o-dianisidine 
as a reducing chromogenic HRP substtate (Bemt and 
Bergmeyer, 1974). Catalase (EC 1.11.1.6) activity was deter-
mmed by following the decrease in H2O2 absorbance in 240 
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n m at 37°C (Aebi, 1984). The catalase reaction is a fu-st-order 
reaction in both enzyme and substtate, precluding the definition 
of an intemational catalase unit. In this study, one catalase unit 
is defined as the activity that will decompose 1 /nmole of H2O2 
per minute at p H 7.0 and 37°C when the H2O2 concenttation falls 
from 10.3 to 9.2 m M . GPx (EC 1.11.1.9) activity was assayed 
by a glutathione reductase-coupled, specttophotometric assay of 
N A D P H absorbance (Flohe and Gunzler, 1984). Glucose-6-phos-
phate dehydrogenase (G6PDH, E C 1.1.1.49) activity was mea-
sured specttophotometrically as an increase in N A D P H ab-
sorbance at 340 n m (Sigma Diagnostics Kit). Reduced 
glutathione levels were quantitated specttophotometrically using 
the GSH-400 assay (Bioxytech, M a m e , France). A U assays were 
performed with Perkin-Elmer Lambda 6 or 14 specttophotome-
ters. Protein quantitation was performed with the B C A assay. 
'3C2,6,6-2H2)glucose (Omicron Biochemicals, South Bend, IN) 
by glycolysis or the PPP produces different ratios of lactate iso-
topomers that are extruded into the medium and quantitated by 
selected ion-monitored gas chromatography/mass specttometry 
(GC/MS). Confluent ceUs in 24-weU culture plates were washed 
twice and incubated for 1 hr in K R B with 5.5 m M labeled glu-
cose and varying concenttations of H2O2 or D-Ala. Triplicate 
wells were used for each experimental condition and samples 
from each well were analyzed in ttiplicate. PPP values were 
cortected for total lactate produced when increasing concen-
ttations of H2O2 or D-Ala inhibited lactate production. PPP stim-
ulation was expressed as the percentage of glucose above basal 
flux that was metabolized through the PPP relative to glycoly-
sis to lactate. 
Cytotoxicity assay 
An automated microculture assay employing the protein-
binding dye sulforhodamine B (SRB, Sigma) was used to quan-
titate growth (Rubenstein et al, 1990; Ben-Yoseph and Ross, 
1994). Cells plated in 96-well culture plates at a density of 
1,000-2,000 cells per well were allowed to grow for 24 hr, 
washed twice with Krebs-Ringer bicarbonate buffer (KRB), 
and exposed to increasing concenttations of H2O2 or d- or l-
Ala in K R B . Following the exposure period of 1-24 hr, cells 
were gently washed twice and allowed to grow in M E M with 
FBS and antibiotics until untreated conttol wells reached sub-
confluence, generally after 4-7 days. The cells were then fixed 
and stained, and the absorbance at 540 n m was measured with 
an AutoReader microtiter plate reader (Cayman Chemicals). 
Toxicity was assessed as the fractional cell survival relative to 
unexposed conttols. At least 16 replicates of each experimen-
tal condition were performed. For B S O sensitization studies, 
cells plated in 96-well plates were cultured ovemight in M E M 
with semm, and subsequentiy incubated with 1 m M L-buthio-
nine-(5./?)-sulfoximine (BSO) in M E M with s e m m for 24 hr 
prior to D-Ala exposure. IC50 values were calculated by non-
linear least-squares regression to a four-parameter logistic func-
tion using SigmaStat software (Jandel Scientific). 
H2O2 assay 
A modification of the phenol red oxidation assay (Pick and 
Keisari, 1980) was used to quantitate H2O2 release by cultured 
cells. Briefly, cells were grown to subconfluence in six-well 
plates, washed twice with K R B , and incubated with 1 ml of K R B 
containing phenol red, H R P, and increasing concenttations of d-
Ala for 1 hr. The buffer was subsequentiy removed, aUcalmized 
with 1 Â^ N a O H , and clarified by centrifugation, and the ab-
sorbance of oxidized phenol red was measured at 610 nm. Stan-
dard curves were generated by addition of 100 X solutions of 
H2O2 in K R B to weUs without D-Ala. H2O2 production was ex-
pressed as nmol/hr per m g cellular protein. Under tiiese condi-
tions tiie assay was linear over the 1-200 nmol/hr per m g range. 
Pentose phosphate pathway flux 
The method for determination of pentose phosphate pathway 
(PPP) activity has been previously described (Ben-Yoseph et 
al, 1994b; Ross et al, 1994). Briefly, metabolism of (1,6-
RESULTS 
Experiments with extracellular DAAO/o-Ala 
Initial experiments were designed to examine the cytotoxic-
ity of D A A O and D-Ala using purified enzyme. Exposure of 9L 
cells to increasing activities of purified Trigonopsis variabilis 
D A A O in the presence of enzyme-samrating concentrations of 
D-Ala revealed dose-dependent toxicity (IC50 of 0.5 mU/well). 
Toxicity was completely abrogated by the addition of excess 
bovine catalase (Fig. 2), indicating that NH3, the other product 
of the D A A O reaction, does not significantly contribute to the 
observed cytotoxicity. 
Expression of R. gracilis DAAO in 9L cells 
The next series of experiments were designed to evaluate the 
feasibility of expressing cytoplasmicaUy targeted R. gracilis 
D A A O in mammalian cells. The R. gracilis D A A O c D N A was 
subcloned into the pcDNA3.1 expression vector under cy-
tomegalovims ( C M V ) promoter/enhancer and mutagenized to 
inttoduce a consensus eukaryotic ttanslation initiation (Kozak) 
100 
D A A O Activity (mU/well) 
FIG. 2. Cytotoxicity of exttacellular DAAO. Cultured 9L 
cells were exposed to increasing amounts of purified Trigonop-
sis variabilis D A A O in the presence of 20 m M D-Ala for 1 hr 
in the absence (•) or presence (O) of 4,000 units of purified 
bovine catalase. Values represent tiie means ± S E (« = 8 
weUs). 
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sequence upstream of the start codon. Introduction of tiie con-
sensus Kozak sequence resulted in mutation of His2 to Asp to 
place a G in the -1-4 position, which immediately follows the 
start codon (Kozak, 1989). A synonymous G-to-C point muta-
tion in codon 102 encoding glycine was also produced during 
tiie polymerase chain reaction (PCR) mutagenesis. W h e n ex-
pressed in Escherichia coli, the His2-Asp mutant had a specific 
activity in the cmde extract similar to the wild-type recombi-
nant enzyme. Site-directed mutagenesis was also used to re-
move the carboxy-terminal type-1 peroxisomal targeting se-
quence (PTSl). The PTS 1-tmncated D A A O mutant was 
expressed in E. coh and purified to homogeneity (Campaner et 
al, 1998). This mutant D A A O is also fully active, character-
ized by a specific activity on D-Ala of 103 U/mg protein at 
25°C, an apparent K ^ of 0.7 m M (125 U/mg protein and 0.83 
m M , respectively, for the wild-type D A A O ) . The mutant also 
dimerized normally and bound its F A D co-enzyme with an 
affinity typical of the wild-type enzyme. 
Stably transfected 9L ceUs were screened qualitatively for 
cytotoxicity induced by exposure to 5 m M D-Ala for 24 hr. A 
clone showing significant sensitivity to D-Ala, 9Ldaaol7, was 
chosen for further analysis. Immunoblotting of sonicated 
9Ldaaon cell extracts with a polyclonal imti-R. gracilis D A A O 
antibody showed the presence of an approximately 40-kD pro-
tein in the transfected cells (Fig. 3, inset lane 3) that co-mi-
grates with purified recombinant R. gracilis D A A O produced 
in E. coli (lane 1). Also present is an approximately 45-kD en-
dogenous protein in parental 9L cells (lane 2) that is recognized 
by the polyclonal antibody, which serves as a convenient gel-
loading control. A peroxidase-coupled specttophotometric as-
say showed that D A A O activity in cmde 9lulaao\l cell extracts 
was 8.8 ± 0.3 U/100 m g protein (mean ± SE, « = 5), which 
cortesponds to approximately 0.06% of the soluble proteins, as-
suming wild-type D A A O specific activity. N o D A A O activity 
was observable in untransfected 9L cells. Moreover, using o-
Ala as a substtate, the D A A O expressed in 9Ldaaoll was found 
to have an apparent A'm of 1.1 m M (Fig. 3). This value is in 
agreement with the measured K ^ value for D A A O purified from 
R. gracilis cells and recombinant wild-type enzyme from E. coli 
(PoUegioni et al, 1992; Campaner et al, 1997). 
Antioxidant enzyme activities 
Specttophotometric assays were employed to determine the 
activities of GPx and catalase, the two major H202-detoxifying 
enzymes in lysates of 9L^aaol7 cells (Fig. 1). GPx activity was 
estimated to be 0.6 ± 0.1 U/100 m g cellular protein (mean ± 
SD, « = 3 separate cellular lysates). Catalase activity was esti-
mated to be 150 ± 18 U/100 m g cellular protein (mean ± SD, 
n = 3 separate cellular lysates) with a starting H2O2 concen-
ttation of 10.3 m M . Although G 6 P D H does not directiy detox-
ify H2O2, it is linked to the GPx-mediated decomposition of 
H2O2 via glutathione reductase and is the rate-determining step 
in N A D P H production by the PPP (Fig. 1). G 6 P D H activity in 
9Ldaaoll extracts was determined to be 9.1 ± 2.1 U/100 m g 
protein (mean ± SD, n = 3 separate cellular lysates). 
Cytotoxicity studies 
Displayed in Fig. 4 A are the results from representative S R B 
cytotoxicity experiments. Exposure of 9ljiaaoll cells to in-
1/[D-Ala] ( m M ) 
FIG. 3. Lineweaver-Burk plot of DAAO activity in cmde 
lysates of 9hdaaon cells, where the x-axis intercept of the lin-
ear regression (r̂  = 0.99) equals — l/K^- Cells were lysed as 
described in pyrophosphate buffer and D A A O activity was mea-
sured at increasing concentrations of D-Ala. (Inset) Immunoblot 
analysis with polyclonal anti-R. gracilis D A A O antibody. Pu-
rified R. gracilis D A A O (lane 1, 0.75 ng) was resolved by a 
1 5 % SDS/PAGE with 4.5 ̂ lg of soluble protein from unttans-
fected 9L cells (lane 2) or 9Ldaaol7 cells (Lane 3). The R. gra-
cilis D A A O band is indicated by the arrowhead. 
creasing concentrations of D-Ala for 24 hr resulted in dose-de-
pendent cytotoxicity with an IC50 of 2.6 ± 0.7 m M (mean ± 
SD, n = 12). Toxicity to parental 9L cells was minimal with 
significant cytotoxicity occurting only at hyperosmolar o-Ala 
concentrations (Fig. 4A). Growth of 9L(iaaol7 was not inhib-
ited by L-Ala (93% survival at 40 m M ; data not shown). In ad-
dition, preincubation of 9Ldaaoll cells with 1 m M B S O for 24 
hr caused a left shift in the dose-response curve (Fig. 4A), re-
sulting in a new IC50 of 0.4 ± 0.2 m M D-Ala (mean ± SD, n = 
11). Specttophotometric assays revealed that B S O treatment de-
pleted G S H levels in 9Ldaaon cells by 90 ± 1 7 % (mean ± 
SD, n = 3). B S O did not enhance D-Ala cytotoxicity for 9L 
parental cells (data not shown). D-Alanine-induced cytotoxic-
ity in 9Ldaao\l cells was also time-dependent (Fig. 4B). 
Oxidative stress 
The phenol red oxidation assay was used to measure pro-
duction of exttacellular H2O2 by cells cultured in the presence 
of D-Ala for 1 hr. 9Ldaao\l cells produced increasing amounts 
of H2O2 in response to increasing concenttations of D-Ala (Fig. 
5 A). Exttacellular concenttations of H2O2 began to increase sig-
nificantly at D-Ala concenttations between 5 and 10 m M . In 
conttast, parental 9L cells did not produce H2O2 in the pres-
ence of D-Ala. 
Stimulation of PPP activity was used as a metabolic indica-
tor of H2O2 detoxification (Ross et al, 1994). W h e n 9Ldaaoll 
cells were exposed to D-Ala for 1 hr, a dose-dependent stimu-
lation of the PPP was observed with a maximal stimulation of 
15.8 ± 1.5% above basal activity achieved between 10 and 20 








FIG. 4. Sensitivity of 9Ldaaon cells to D-Ala. A. Unttans-
fected 9L cells (D) and 9Ldaaoll ceUs with (•) or without 
(O) a 24-hr pretteatment with 1 m M B S O were exposed to in-
creasing concenttations of o-Ala for 24 hr. Values represent the 
mean ± SE (n = 8 wells) from representative experiments. B. 
Time dependence of D-Ala growth inhibition. 9Ldaaon cells 
were incubated with increasing concenttations of D-Ala for 1, 
3, 6, 12, or 24 hr. The IC50 values (± SE, n = 8 wells per con-
centtation) are from single representative experiments. 
m M D-Ala (Fig. 5B). In conttast, D-Ala at concenttations as 
high as 40 m M did not elicit significant stimulation of glucose 
flux through the PPP in parental 9L cells (Fig. 5B; maximal 
stimulation 1.6 ± 0.5%). Moreover, expression of R. gracilis 
D A A O in 9Ldaaol7 cells did not significantiy affect the basal 
PPP activity (data not shown). Bolus addition of H2O2 also stim-
ulated PPP glucose flux in 9lxlaaoll cells in a dose-dependent 
fashion, reaching a saturation level of 19.3 ± 1.5% above base-
line at about 600 p M (Fig. 5C), which is consistent with the 
maximal H202-induced stimulation of the PPP in parental 9L 
cells (Ben-Yoseph et al, 1994a). It should also be noted that 
exttacellular addition of purified D A A O stimulated PPP activ-
ity in the presence of D-Ala to the same extent as preformed 
H2O2 (data not shown). Furthermore, this stimulation was com-














15 20 25 
[D-Ala] ( m M ) 






FIG. 5. H2O2 production and metabolism by 9lAaaoll cells. 
A. Exttacellular H2O2 production by parental 9L cells (O) and 
9Ldaaon cells (•) culmred in six-well plates with increasing 
concenttations of D-Ala. Values are means ± SE from a rep-
resentative experiment (n = 6 wells per concenttation). B. The 
glucose flux through the PPP was monitored by G C / M S analy-
sis of lactate isotopomers extmded from 9L cells (O) and 
9Ldaaon cells (•) cultured in 24-well plates with (1,6-
'^C2,6,6-2H2)glucose and increasing concenttations of D-Ala 
for 1 hr. C. Stimulation of glucose flux through tiie PPP by bo-
lus addition of increasing concenttations of preformed H2O2. 
Values for all PPP assays are means ± SE (« = 9 wells per 
concenttation from three separate experiments). 
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DISCUSSION 
A major problem in the clinical management of cancer pa-
tients is the limited differential toxicity of chemotherapeutic 
agents and radiation toward neoplastic versus normal cells. 
Gene ttansfer technology offers the possibility of surmounting 
tills limitation by inttoducing unique d m g targets into malig-
nant cells. G D E P T paradigms for cancer gene therapy depend 
on expressing genes encoding nonmammalian enzymes that 
convert pharmacologically inert prodmgs to highly toxic 
metabolites. The studies reported here demonstrate the poten-
tial of inttacellular expression of R. gracilis D A A O together 
with administtation of D-Ala as a G D E P T protocol. 
Prior to conducting ttansfection experiments, the cytotoxic-
ity of purified D A A O against 9L ceUs was tested. In the pres-
ence of D-Ala, exttacellular D A A O was cytotoxic at low lev-
els of activity and with brief periods of exposure (Fig. 2). The 
IC50 was 0.5 mU/well, which over the 1-hr incubation period 
is calculated to produce 0.03 pmol of H2O2, cortesponding to 
a cumulative concenttation of 150 p M . This is consistent with 
the 60 p M IC50 for preformed H2O2 previously reported for 9L 
cells (Ben-Yoseph and Ross, 1994) allowing for the difference 
between the bolus addition of preformed H2O2 versus its en-
zymatic production by exttacellular D A A O over 1 hr. 
To produce cytoplasmic D A A O , the c D N A encoding R. gra-
cilis D A A O was tmncated to remove its type-1 peroxisomal 
targeting sequence. The altered c D N A directed production of 
functional D A A O in both E. coli and 9 L d a a o n cells, indicat-
ing that its peroxisomal targeting sequence is not requtted for 
enzymatic activity (Campaner et al, 1998). SimUarly, expres-
sion of the mutant enzyme in 9hdaaoll cells did not signifi-
cantly alter its apparent K ^ for D-Ala using the cmde exttact 
(Fig. 3). W e attempted to confirm the cytoplasmic localization 
of the mutant D A A O in 9l.daaoll cells with immunofluores-
cence microscopy. D A A O appeared to be located in the cyto-
plasm (data not shown), however, definitive assignment of a 
cytoplasmic localization will require epitope-tagging of/?, gra-
cilis D A A O because 9L cells contain an unidentified protein 
that cross-reacts with the affinity-purified rabbit antisera to the 
yeast homolog (Fig. 3, inset). The observation that cytotoxic-
ity occurs in 9hdaaoll cells despite the presence of 150 U/100 
m g of catalase further implies cytosolic localization of D A A O . 
This is consistent with the ability of 8.8 U/100 m g of D A A O 
to overwhelm the detoxification capacity of 0.6 U/100 m g of 
G P x in the cytoplasm of 9Ldaaoll cells. The fact that the max-
imal stimulation of glucose flux through the PPP by D-Ala and 
performed H2O2 in 9hdaaoll cells was similar (Fig. 5B,C) fur-
ther supports this interpretation. Additionally, extmsion of 
H2O2 from 9 L d a a o n cells dramatically increased at concen-
ttations of D-Ala between 5 and 10 m M (Fig. 5A). This corte-
lates with the concenttation of D-Ala at which PPP stimulation 
was maximal (Fig. 5B), indicating that GPx-mediated H2O2 re-
moval was saturated. Thus, the intracellular half-life of H2O2 
would be expected to be prolonged, providing a greater proba-
bility for its diffusion out of the cell. The presence of extta-
cellular H2O2 suggests that H2O2 produced by ttansduced cell 
"factories" should kill adjacent untransduced cells in a process 
known as "bystander" killing (Freeman et al., 1993). 
The toxic product of this therapeutic sttategy, H2O2, is toxic 
to both proliferating and quiescent cells (Vidair and Dewey, 
1991); in conttast, the most commonly investigated G D E P T 
protocols generate cytotoxic agents that are specific for actively 
proliferating cells (Connors, 1995). In support of the toxicity 
of H2O2 for nonproliferating cells, we have conducted qualita-
tive experiments in which confluent 9Ldaaoll cells were ex-
posed to 10 m M D-Ala ovemight. Under these conditions, the 
cells were kUled and detached from the culture plate (data not 
shown). The ability to kill noncycling cells is an attractive fea-
ture because a substantial fraction of cells within solid tumors 
may be quiescent (Yoshii etal, 1986). Although H2O2 has been 
shown to induce programmed cell death in a number of cell 
types, apoptosis may not be the mechanism underlying the cy-
totoxicity of D A A O gene therapy due to the relatively large 
amounts of inttacellular peroxide generated. Further investiga-
tions are curtentiy underway to elucidate the mechanism of cell 
death. 
In the context of primary C N S malignancies, we have pre-
viously shown that cultured glioma cells are intrinsically more 
susceptible to oxidative injury induced by H2O2 (IC50 = 60 
juAf) than cultured primary neuronal (IC50 = 1 0 0 p M ) or as-
trocytic cells (IC50 = 600 p M ) (Ben-Yoseph and Ross, 1994). 
A recent study also described an inverse cortelation between 
the histological grade and antioxidant enzyme activities in a se-
ries of human central nervous system (CNS) malignancies (Pu 
et al, 1996). The authors of this study also reported that the 
mean GPx activity in 17 high-grade human gliomas was 1.1 ± 
0.2 U/100 mg, which is comparable to the levels w e observed 
in 9L cells. AdditionaUy, a wide artay of agents that interfere 
with cellular antioxidant repair mechanisms are avaUable. These 
include enzyme inhibitors, thiol-depleting dmgs, and DNA-re-
pair inhibitors, all of which have been used as radiosensitizers. 
W e previously reported that preincubation of 9L cells with B S O 
resulted in a three-fold sensitization to H202-induced toxicity 
(IC50 = 20 p M ) , thereby increasing their differential toxicity to 
H2O2 to five- and thirty-fold more than primary neuronal and 
asttocytic cultures, respectively (Ben-Yoseph and Ross, 1994; 
Ben-Yoseph et al, 1994a). SimUarly, the studies described 
herein showed that B S O further sensitizes 9Ldaaoll cells to d-
Ala (Fig. 4A). The ability to sensitize cells further to the D A A O 
gene therapy protocol with a wide variety of agents is unique 
among G D E P T sttategies and is particularly exciting for appli-
cation to neuro-oncology because administtation of B S O to 
mice bearing intracranial gliomas resulted in a selective deple-
tion of G S H in the tumors while normal brain G S H levels re-
mained intact (Skapek et al, 1988). This is especially promis-
ing because cellular glutathione content rather than antioxidant 
enzyme activities was the main predictor of the H2O2 sensitiv-
ity of six murine tumor models (Nathan et al, 1980). 
The application of this negative selective system to in vivo 
cancer gene therapy awaits tiie results of a number of experi-
ments. Most importantly, the pharmacokinetic properties of d-
amino acids must be characterized to devise appropriate dos-
ing schedules for evaluating the efficacy of the D A A O gene 
therapy approach in animal models. Eventually w e hope that 
D A A O gene therapy will prove synergistic with multimodality 
brain tumor tteatment protocols including surgery, radiation, 
and chemotherapy. The fact that carmustine ( B C N U ) , the main-
line chemotherapeutic for malignant gliomas, is a potent and 
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specific inhibitor of glutathione reductase and has been shown 
to sensitize tomor cells to H2O2 up to 18.7-fold (Nathan et al, 
1980) supports this assertion. 
In conclusion, this study demonsttated that the cytotoxicity 
of R O S can be harnessed by the expression of D A A O in tomor 
cells by gene ttansfer techniques. Exposure of tomor cells to d-
Ala resulted in the cytotoxic overproduction of R O S . This novel 
gene therapy paradigm possesses several potential advantages 
over other G D E P T systems, (i) The H2O2 product is cell cycle 
nonspecific, (ii) H2O2 has similar cell permeability character-
istics to water, thus providing the rationale for achieving by-
stander killing, (iii) Tumor cells can be presensitized to oxida-
tive damage prior to tteatment with DAAO/o-Ala. (iv) The 
D-amino acid substtates for D A A O (e.g., D-Ala) are essentially 
nontoxic. 
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